Medication info
Roxva Tablet 10mg (Rosuvastatin Calcium)

Roxva Tablet 10mg (Rosuvastatin Calcium)

Prescription medicationTablet
Ingredient · strength
Rosuvastatin Calcium›10.4mg / 1 tablet
Manufacturer / importer
Korea Pavis Pharmaceutical Co., Ltd.
Appearance
Pink round film-coated tablet
Packaging
30 tablets/bottle
Approval status
Active

MFDS item code 201502366 · Approved 2015.04.17 · Insurance code 621802670

Summary

Main use
Improvement of dyslipidemia, reduction of cardiovascular disease risk, and inhibition of atherosclerosis progression
Who uses it
Adults · Children
Adult dosage
1. Primary hypercholesterolemia (type IIa, including heterozygous familial hypercholesterolemia), mixed dyslipidemia (type IIb), primary dysbetalipoproteinemia (type III), and homozygous familial hypercholesterolemia Patients should follow a standard cholesterol-lowering diet before and during treatment with this medicine and continue it throughout the treatment period. This medicine may be taken at any time of day, with or without food. The initial dose is 5 milligrams once daily; the dose may be adjusted to a maintenance dose if greater reduction in LDL cholesterol is needed. The maintenance dose is 10 milligrams once daily, which controls the condition in most patients. The maintenance dose should be adjusted as appropriate at intervals of 4 weeks or longer, according to LDL cholesterol levels, treatment goals, and the patient's response; it may be increased to a maximum of 20 milligrams daily. 3. Elderly: No dosage adjustment is required. 4. Patients with renal impairment: No dosage adjustment is required in patients with mild or moderate renal impairment. Do not administer to patients with severe renal impairment. Use particular caution when administering this medicine 20mg to patients with moderate renal impairment. 5. Patients with hepatic impairment: No increase in systemic exposure to rosuvastatin was observed in patients with a Child-Pugh score of 7 or less, but an increase was observed in patients with a Child-Pugh score of 8 or 9. Renal function testing should be considered in these patients. There is no experience with administration to patients with a Child-Pugh score greater than 9. Do not administer this medicine to patients with active liver disease. 6. Race: Because systemic exposure to this medicine is increased in Asian patients, the recommended initial dose is 5 milligrams. Administration of the 40 milligrams dose is contraindicated. 7. Patients predisposed to myopathy: The recommended initial dose for patients predisposed to myopathy is 5 milligrams. Administration of the 40 milligrams dose is contraindicated in some of these patients.
Children's dosage
Aged 10 ~ 17 years: The usual dosage range is 5 milligrams ~ 20 milligrams once daily. (There are no clinical data on doses higher than 20 milligrams in pediatric patients.) Under 10 years of age: Safety and efficacy have not been established.

Ingredients

Manufacturer
Korea Pavis Pharmaceutical Co., Ltd.

Efficacy & effects

Improvement of dyslipidemia, reduction of cardiovascular disease risk, and inhibition of atherosclerosis progression

  • Primary hypercholesterolemia
  • heterozygous familial hypercholesterolemia
  • mixed dyslipidemia
  • homozygous familial hypercholesterolemia
  • hypercholesterolemia
  • atypical familial hypercholesterolemia
  • excessive LDL cholesterol
  • excessive total cholesterol
  • excessive Apo-B protein levels
  • primary dysbetalipoproteinemia
  • excessive high-sensitivity C-reactive protein
  • hypertension
View approved original text

This medication is used in various situations associated with hypercholesterolemia. It is helpful for patients with primary hypercholesterolemia and mixed dyslipidemia who are not regulated by diet and exercise alone. It is also used in conjunction with dietary therapy in patients with familial hypercholesterolemia, and it can be applied especially for children and adolescents. It lowers total cholesterol and LDL cholesterol levels, delaying the progression of atherosclerosis, and is used as an adjunctive therapy in dietary management of patients with dysbetalipoproteinemia. Moreover, it is effective in reducing the risk of cardiovascular events such as stroke and myocardial infarction in middle-aged people at high risk for cardiovascular disease. Overall, this medication is used for improving blood cholesterol levels and preventing cardiovascular diseases.

Dosage and Administration

Adult dosage

1. Primary hypercholesterolemia (type IIa, including heterozygous familial hypercholesterolemia), mixed dyslipidemia (type IIb), primary dysbetalipoproteinemia (type III), and homozygous familial hypercholesterolemia Patients should follow a standard cholesterol-lowering diet before and during treatment with this medicine and continue it throughout the treatment period. This medicine may be taken at any time of day, with or without food. The initial dose is 5 milligrams once daily; the dose may be adjusted to a maintenance dose if greater reduction in LDL cholesterol is needed. The maintenance dose is 10 milligrams once daily, which controls the condition in most patients. The maintenance dose should be adjusted as appropriate at intervals of 4 weeks or longer, according to LDL cholesterol levels, treatment goals, and the patient's response; it may be increased to a maximum of 20 milligrams daily. 3. Elderly: No dosage adjustment is required. 4. Patients with renal impairment: No dosage adjustment is required in patients with mild or moderate renal impairment. Do not administer to patients with severe renal impairment. Use particular caution when administering this medicine 20mg to patients with moderate renal impairment. 5. Patients with hepatic impairment: No increase in systemic exposure to rosuvastatin was observed in patients with a Child-Pugh score of 7 or less, but an increase was observed in patients with a Child-Pugh score of 8 or 9. Renal function testing should be considered in these patients. There is no experience with administration to patients with a Child-Pugh score greater than 9. Do not administer this medicine to patients with active liver disease. 6. Race: Because systemic exposure to this medicine is increased in Asian patients, the recommended initial dose is 5 milligrams. Administration of the 40 milligrams dose is contraindicated. 7. Patients predisposed to myopathy: The recommended initial dose for patients predisposed to myopathy is 5 milligrams. Administration of the 40 milligrams dose is contraindicated in some of these patients.

Children's dosage

Aged 10 ~ 17 years: The usual dosage range is 5 milligrams ~ 20 milligrams once daily. (There are no clinical data on doses higher than 20 milligrams in pediatric patients.) Under 10 years of age: Safety and efficacy have not been established.

Precautions

This medication should not be used by patients who are allergic to specific components. Patients with active liver disease or significantly elevated liver enzymes should not take this medication. Patients with muscle disease or muscle problems should avoid this drug, and patients with certain autoimmune diseases should also exercise caution. Patients taking cyclosporine or those with severely impaired kidney function should preferably not use this medication. Women who are pregnant or breastfeeding, as well as fertile women not using appropriate contraception, should not take this medication, and women of childbearing age may use it only if they are fully aware of the risks of pregnancy and fetal hazards. Patients at high risk for muscle diseases, such as moderate renal impairment, hypothyroidism, genetic history of muscle disease, alcohol dependence, Asians, and patients receiving fibrate medications should avoid high doses. This medication contains lactose and should not be taken by patients with lactose intolerance or related genetic conditions. Patients with a history of liver disease or who consume alcohol excessively should undergo regular liver function tests, and those with hypothyroidism or nephrotic syndrome should take this medication only after treating the underlying conditions. Muscle-related symptoms such as myalgia or myopathy, and in severe cases, rhabdomyolysis, may occur, so if any muscle-related symptoms appear, the patient should immediately notify a physician and undergo testing. In particular, if muscle enzyme levels rise significantly, the medication should be discontinued, and re-administration at a lower dose may be considered once symptoms and levels return to normal. In acute severe conditions, the administration of this medication should be stopped, and it should not be used if symptoms of severe myasthenia gravis or ocular myasthenia gravis are present, as it may exacerbate these conditions. Caution is also needed, especially when used in combination with certain medications, as there may be a higher risk of muscle-related side effects, particularly with gemfibrozil. Kidney function tests may be necessary with high-dose use. Asian patients may have higher concentrations of the medication, so dosage adjustment may be required. In children and adolescents, the evaluation of effects on growth and development is limited, so caution is advised. This drug may cause mild side effects such as headache, dizziness, gastrointestinal discomfort, rash, myalgia, weakness, hematuria, diarrhea, joint pain, fatigue, numbness, sensory disturbances, chest discomfort, decreased appetite, abdominal bloating, syncope, generalized pain, muscle cramps, gout, erectile dysfunction, memory loss, peripheral neuropathy, cough, thrombocytopenia, increased transaminases, hepatitis, drug rash resembling lichen planus, lupus-like syndrome, muscle rupture, arthralgia, depression, sleep disturbances, and others. Rarely, severe liver damage, muscle diseases, severe skin reactions, and other abnormal symptoms may occur, so if any unusual symptoms appear, immediate consultation with healthcare personnel is essential. The medication should not be used during pregnancy or breastfeeding, and women planning pregnancy should use appropriate contraception. There is no specific antidote for overdose, so treatment should be symptomatic, and liver function and muscle enzyme tests may be necessary. Caution is required when driving or operating machinery due to potential dizziness. This drug may interact with many other medications, so if taking other drugs, it is essential to consult with a physician or pharmacist. Particular caution is advised when used in combination with specific antiviral agents, immunosuppressants, antifungals, antibiotics, and fibrate medications.

Side effects

Allergic reactions including angioedema, diabetes, headache, dizziness, constipation, nausea, abdominal pain, pancreatitis, itching, rash, hives, myalgia, myopathy, rhabdomyolysis, asthenia, polyneuropathy, amnesia, peripheral neuropathy, myasthenia gravis, cough, dyspnea, diarrhea, oculobulbar weakness, thrombocytopenia, jaundice, hepatitis, increased transaminases, Stevens-Johnson syndrome, eosinophilia with systemic symptoms associated drug reaction syndrome, lichenoid drug eruption, lupus-like syndrome, muscle rupture, arthralgia, immune-mediated necrotizing myopathy, hematuria, edema, depression, sleep disorders, interstitial lung disease, sexual dysfunction, gynecomastia, fatal and non-fatal liver failure, cognitive impairment, increased ALT, chest pain, muscle cramps, gout, erectile dysfunction, numbness, paresthesia, chest discomfort, anorexia, abdominal bloating, syncope, generalized pain, fatigue

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a sealed container to prevent exposure to air or moisture, and it is recommended to keep it at room temperature between 1°C and 30°C. Storing it this way will maintain the effectiveness and safety of the medication.

Appearance and packaging

Appearance

Pink round film-coated tablet

Package unit

30 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.